
Catalyst Pharmaceuticals Inc
CPRXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$31.29
Day High
$31.34
Day Low
$31.23
Prev. Close
$31.29
VolumeShares traded today.
2.23M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$3.82B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
17.95
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$32.56
52W LowLowest price over the past 52 weeks.
$19.05
50D MAAverage closing price over the last 50 trading days.
$27.65
200D MAAverage closing price over the last 200 trading days.
$23.66
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-0.2%1M
+10.5%6M
+32.4%YTD
+34.9%1Y
+25.4%About
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
catalystpharma.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CPRX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.